Structure Therapeutics Inc ADR [GPCR] stock prices are down -1.57% to $30.07 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The GPCR shares have gain 10.23% over the last week, with a monthly amount glided 44.01%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Structure Therapeutics Inc ADR [NASDAQ: GPCR] stock has seen the most recent analyst activity on May 02, 2025, when Citigroup initiated its Buy rating and assigned the stock a price target of $60. On January 08, 2025, Stifel initiated with a Buy rating and assigned a price target of $50 on the stock. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $80 on December 04, 2024. Morgan Stanley initiated its recommendation with a Overweight and recommended $118 as its price target on September 23, 2024. JP Morgan started tracking with a Overweight rating for this stock on May 21, 2024, and assigned it a price target of $65. In a note dated April 09, 2024, Cantor Fitzgerald initiated an Overweight rating and provided a target price of $65 on this stock.
The stock price of Structure Therapeutics Inc ADR [GPCR] has been fluctuating between $13.22 and $42.57 over the past year. Currently, Wall Street analysts expect the stock to reach $92.4 within the next 12 months. Structure Therapeutics Inc ADR [NASDAQ: GPCR] shares were valued at $30.07 at the most recent close of the market. An investor can expect a potential return of 207.28% based on the average GPCR price forecast.
Analyzing the GPCR fundamentals
Gross Profit Margin for this corporation currently stands at -0.52% with Operating Profit Margin at -123.45%, Pretax Profit Margin comes in at -100.32%, and Net Profit Margin reading is -100.58%. To continue investigating profitability, this company’s Return on Assets is posted at -0.22, Equity is -0.21 and Total Capital is -0.28. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Structure Therapeutics Inc ADR [NASDAQ:GPCR]’s Current Ratio is 20.48. In addition, the Quick Ratio stands at 20.48 and the Cash Ratio stands at 3.77.
